Education
About Us
Working with TipRanks
Follow Us
Immunic (IMUX)
NASDAQ:IMUX
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ 0.00 | $ -111.00K | $ -77.00K | $ -85.00K | $ -39.00K |
| Operating Income | $ -98.05M | $ -99.22M | $ -119.49M | $ -91.67M | $ -48.97M |
| EBITDA | $ -100.37M | $ -99.11M | $ -120.33M | $ -92.86M | $ -48.93M |
| Net Income | $ -100.51M | $ -93.61M | $ -154.30M | $ -92.79M | $ -43.96M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 35.67M | $ 46.67M | $ 116.37M | $ 86.86M | $ 127.45M |
| Total Assets | $ 40.87M | $ 54.30M | $ 127.75M | $ 139.10M | $ 167.86M |
| Total Debt | $ 1.00M | $ 1.33M | $ 1.56M | $ 584.00K | $ 679.00K |
| Net Debt | $ -34.66M | $ -45.34M | $ -105.18M | $ -86.28M | $ -126.77M |
| Total Liabilities | $ 22.44M | $ 25.37M | $ 14.07M | $ 11.98M | $ 9.08M |
| Stockholders' Equity | $ 18.43M | $ 28.93M | $ 113.68M | $ 127.11M | $ 158.78M |
| Cash Flow | |||||
| Free Cash Flow | $ -85.03M | $ -71.16M | $ -65.26M | $ -83.30M | $ -46.27M |
| Operating Cash Flow | $ -84.77M | $ -70.83M | $ -65.14M | $ -83.23M | $ -46.12M |
| Investing Cash Flow | $ -264.00K | $ 9.46M | $ -9.74M | $ -67.00K | $ -146.00K |
| Financing Cash Flow | $ 74.54M | $ 1.03M | $ 95.76K | $ 42.84K | $ 144.43M |
Immunic Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.